Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients?

Resino S, Bellón JM, Asensio C, Micheloud D, Miralles P, Vargas A, Catalán P, López JC, Alvarez E, Cosin J, Lorente R, Muñoz-Fernández MA, Berenguer J.

BMC Infect Dis. 2010 Aug 19;10:244. doi: 10.1186/1471-2334-10-244.

2.

APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis.

El Serafy MA, Kassem AM, Omar H, Mahfouz MS, El Said El Raziky M.

Arab J Gastroenterol. 2017 Jun;18(2):51-57. doi: 10.1016/j.ajg.2017.05.005. Epub 2017 Jun 1. Review.

PMID:
28579340
3.

Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.

Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY.

Hepatology. 2011 Mar;53(3):726-36. doi: 10.1002/hep.24105. Epub 2011 Feb 11. Review.

PMID:
21319189
4.

Coinfection by human immunodeficiency virus and hepatitis C virus: noninvasive assessment and staging of fibrosis.

Resino S, Sánchez-Conde M, Berenguer J.

Curr Opin Infect Dis. 2012 Oct;25(5):564-9. doi: 10.1097/QCO.0b013e32835635df. Review.

PMID:
22744318
5.

A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.

Ahmad W, Ijaz B, Gull S, Asad S, Khaliq S, Jahan S, Sarwar MT, Kausar H, Sumrin A, Shahid I, Hassan S.

Virol J. 2011 Feb 8;8:53. doi: 10.1186/1743-422X-8-53. Review.

6.

Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV.

Matta B, Lee TH, Patel K.

Curr HIV/AIDS Rep. 2016 Oct;13(5):279-88. doi: 10.1007/s11904-016-0329-5. Review.

PMID:
27485838
7.

Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.

Stauber RE, Lackner C.

World J Gastroenterol. 2007 Aug 28;13(32):4287-94. Review.

8.

Non-invasive prediction of forthcoming cirrhosis-related complications.

Kang W, Kim SU, Ahn SH.

World J Gastroenterol. 2014 Mar 14;20(10):2613-23. doi: 10.3748/wjg.v20.i10.2613. Review.

9.

The role of serum hyaluronic acid determination in the diagnosis of liver fibrosis.

Gudowska M, Cylwik B, Chrostek L.

Acta Biochim Pol. 2017;64(3):451-457. doi: 10.18388/abp.2016_1443. Epub 2017 Jul 19. Review.

10.

Liver fibrosis markers in alcoholic liver disease.

Chrostek L, Panasiuk A.

World J Gastroenterol. 2014 Jul 7;20(25):8018-23. doi: 10.3748/wjg.v20.i25.8018. Review.

11.

Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application.

Babaei Z, Parsian H.

Hepatobiliary Pancreat Dis Int. 2016 Apr;15(2):131-40. Review.

PMID:
27020628
12.

Non-invasive diagnosis of liver fibrosis in chronic hepatitis C.

Schiavon Lde L, Narciso-Schiavon JL, de Carvalho-Filho RJ.

World J Gastroenterol. 2014 Mar 21;20(11):2854-66. doi: 10.3748/wjg.v20.i11.2854. Review.

13.

Non-invasive diagnosis of liver fibrosis and cirrhosis.

Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ.

World J Gastroenterol. 2015 Nov 7;21(41):11567-83. doi: 10.3748/wjg.v21.i41.11567. Review.

14.

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy.

Sebastiani G, Alberti A.

World J Gastroenterol. 2006 Jun 21;12(23):3682-94. Review.

15.

Chronic hepatitis C and liver fibrosis.

Sebastiani G, Gkouvatsos K, Pantopoulos K.

World J Gastroenterol. 2014 Aug 28;20(32):11033-53. doi: 10.3748/wjg.v20.i32.11033. Review.

16.

[Options for non-invasive assessment of liver fibrosis based on clinical data].

Egresi A, Lengyel G, Hagymási K.

Orv Hetil. 2015 Jan 11;156(2):43-52. doi: 10.1556/OH.2015.30069. Review. Hungarian.

PMID:
25563681
17.

The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy.

Xu XY, Kong H, Song RX, Zhai YH, Wu XF, Ai WS, Liu HB.

PLoS One. 2014 Jun 25;9(6):e100182. doi: 10.1371/journal.pone.0100182. eCollection 2014. Review.

18.

Performance of serum marker panels for liver fibrosis in chronic hepatitis C.

Parkes J, Guha IN, Roderick P, Rosenberg W.

J Hepatol. 2006 Mar;44(3):462-74. Epub 2005 Nov 21. Review.

PMID:
16427156
19.

Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.

Valva P, Ríos DA, De Matteo E, Preciado MV.

World J Gastroenterol. 2016 Jan 28;22(4):1367-81. doi: 10.3748/wjg.v22.i4.1367. Review.

20.

Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis.

Rostami S, Parsian H.

Hepat Mon. 2013 Dec 14;13(12):e13787. doi: 10.5812/hepatmon.13787. Review.

Supplemental Content

Support Center